Associated Pharma Traders Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.36 M
- Company Age 40 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.09 M
- Revenue Growth 7.81%
- Profit Growth 11.09%
- Ebitda 17.24%
- Net Worth 70.51%
- Total Assets 11.12%
About Associated Pharma Traders
Associated Pharma Traders Pvt. Ltd. (APTPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 November 1984 and has a history of 40 years and three months. Its registered office is in ,Rajasthan, Rajasthan.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.36 M.
The company currently has active open charges totaling ₹1.09 M.
Anil Sehgal and Sushil Sehgal serve as directors at the Company.
Company Details
- Location ,Rajasthan, Rajasthan
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232RJ1984PTC003143
-
Company No.
003143
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Nov 1984
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Associated Pharma Traders?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Sehgal
|
Director | 12-Nov-1984 | Current |
|
Sushil Sehgal
|
Director | 12-Nov-1984 | Current |
Financial Performance of Associated Pharma Traders.
Associated Pharma Traders Pvt. Ltd., for the financial year ended 2020, experienced modest growth in revenue, with a 7.81% increase. The company also saw a substantial improvement in profitability, with a 11.09% increase in profit. The company's net worth Soared by an impressive increase of 70.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Associated Pharma Traders?
In 2019, Associated Pharma Traders had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Crown Pharmaceuticals P. Ltd.Anil Sehgal and Sushil Sehgal are mutual person
Charges (Loans)
₹1.09 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.11 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2021 | Hdfc Bank Limited | ₹1.09 M | Open |
How Many Employees Work at Associated Pharma Traders?
Unlock and access historical data on people associated with Associated Pharma Traders, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Associated Pharma Traders, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Associated Pharma Traders's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
